Skip to main content
    S

    Senseonics Holdings, Inc. Common Stock (SENS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $8.59
    +0.60 (+7.51%)

    Market Cap: $476.92M

    Last updated: Nov 06, 2026 at 4:43 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(15/39)
    Avg Surprise
    -57.87%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.52
    Range$-0.64 - $-0.41
    7 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.60+13.3%
    60d ago$-0.53+1.8%
    30d ago$-0.53+1.8%
    7d ago$-0.520.0%
    Current$-0.52
    Revenue Consensus
    $16M
    Range$16M - $17M
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.44
    Range$-0.67 - $-0.23
    7 analysts
    Revenue Consensus
    $25M
    Range$24M - $27M
    7 analysts
    Last 12 of 39 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.44$-0.67 - $-0.23--7--
    Sep 26EST
    		-$-0.52$-0.64 - $-0.41--7
    2
    0
    30d
    		-
    Jun 26
    Reported Aug 6
    		$-0.63$-0.55$-0.73 - $-0.50-14.55%Miss6
    5
    1
    30d
    		-57.5%
    Mar 26
    Reported May 7
    		$-0.71$-0.70$-0.74 - $-0.62-1.43%Miss7
    1
    6
    30d
    		-77.5%
    Dec 25
    Reported Mar 2
    		$-0.46$-0.02$-0.10 - $0.01-2373.12%Miss7
    1
    0
    30d
    		-2200.0%
    Sep 25
    Reported Nov 5
    		$-0.43$-0.33$-0.34 - $-0.33-30.30%Miss5
    2
    0
    30d
    		+46.3%
    Jun 25
    Reported Aug 6
    		$-0.40$-0.40$-0.40 - $-0.40+0.00%Beat6
    2
    0
    30d
    		+39.4%
    Mar 25
    Reported May 8
    		$-0.40$-0.47$-0.48 - $-0.47+14.89%Beat3
    2
    0
    30d
    		+33.3%
    Dec 24
    Reported Mar 3
    		$-0.02$-0.03$-0.03 - $-0.03+33.33%Beat2
    0
    1
    30d
    		+33.3%
    Sep 24
    Reported Nov 7
    		$-0.80$-0.70$-0.71 - $-0.70-14.29%Miss5
    No revisions (30d)
    		+15.8%
    Jun 24
    Reported Aug 8
    		$-0.66$-0.60$-0.60 - $-0.60-10.00%Miss4
    No revisions (30d)
    		+7.0%
    Mar 24
    Reported May 13
    		$-0.60$-0.60$-0.60 - $-0.60+0.00%Beat3
    No revisions (30d)
    		+35.5%
    Dec 23
    Reported Feb 29
    		$-0.03$-0.04$-0.05 - $-0.04+25.00%Beat3
    No revisions (30d)
    		-250.0%
    Sep 23
    Reported Nov 9
    		$-0.95$-0.70$-0.71 - $-0.70-35.71%Miss4
    No revisions (30d)
    		+63.5%

    Key Metrics

    Valuation
    P/E Ratio-3.85EV/EBITDAN/A
    Price/FCF-5.13xFCF Yield-19.49%
    Profitability
    Profit Margin-225.30%Operating Margin-248.50%
    ROE-118.20%ROIC-58.69%
    Financial Health
    Debt/Equity0.62xInterest Coverage-21.00x
    Current Ratio6.74xQuick Ratio6.40x
    Trading Statistics
    Beta1.03Avg Volume633.50K
    52-Week High$10.6452-Week Low$4.79

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.79
    SMA 20$8.46
    SMA 50$9.11
    SMA 200$7.24
    EMA 10$8.66
    EMA 20$8.70
    EMA 50$8.64
    EMA 200$7.85

    MACD

    Line: -0.07Signal: -0.11Hist: 0.04

    ADX

    ADX: 20.8+DI: 21.7-DI: 27.0

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down60.0
    PSAR$9.71

    Bollinger Bands

    Upper Band$9.88
    Lower Band$7.05
    %B Position3344%(Upper)
    Band Width0.55

    RSI (14-Day)

    Neutral
    48.6

    Momentum Oscillators

    Stoch %K51.3
    Stoch %D58.1
    Williams %R-46.4
    ROC (10d)14.4%
    Momentum1.08
    CCI (20d)-12.9
    MFI (14d)52.0

    Volatility Measures

    ATR (14d)$0.65(7.5%)
    StdDev (20d)0.71
    Hist Vol99.1%(High)

    Volume Flow

    VWAP$8.36
    OBV-131.7M
    AD Line557.2B
    CMF (20d)-0.014

    Volume Metrics

    Avg Vol (20d)633.6K
    Vol Ratio1.4x
    VWMA (20d)$8.53

    Pivot Points

    R3$9.84
    R2$9.44
    R1$8.71
    Pivot Point$8.31
    S1$7.59
    S2$7.19
    S3$6.46

    Advanced Oscillators

    TSI-3.12
    Ultimate Osc46.5
    KST-62.59

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$14.48M$11.71M$14.26M$8.10M$6.65M$6.26M$8.30M$4.26M$4.87M$5.05M$8.03M$6.10M
    Cost of Revenue$5.92M$4.77M$6.59M$4.63M$3.53M$4.75M$4.35M$8.31M$4.57M$4.71M$6.94M$4.92M
    Gross Profit$8.56M$6.94M$7.67M$3.47M$3.12M$1.50M$3.95M$-4,051,000$298,000$335,000$1.09M$1.17M
    Operating Expenses$44.55M$38.79M$28.59M$23.07M$17.44M$14.99M$18.22M$18.80M$19.79M$18.57M$18.09M$20.19M
    R&D$11.64M$8.61M$8.82M$7.76M$7.71M$7.30M$9.36M$10.55M$10.80M$10.44M$10.75M$12.77M
    SG&A$32.91M$30.18M$19.77M$15.31M$9.73M$7.69M$8.86M$8.25M$8.99M$8.13M$7.34M$7.42M
    Operating Income$-35,988,000$-31,846,000$-20,925,000$-19,601,000$-14,323,000$-13,488,000$-14,270,000$-22,847,000$-19,493,000$-18,232,000$-17,004,000$-19,022,000
    Interest Income$1.03M$742,000$1.31M$1.24M$973,000$675,000$918,000$1.01M$1.19M$1.38M$1.48M$1.46M
    Interest Expense$1.60M$1.19M$1.21M$1.17M$1.15M$1.43M$2.17M$2.13M$2.08M$2.05M$1.72M$2.42M
    Income Before Tax$-36,705,000$-32,333,000$-20,823,000$-19,530,000$-14,501,000$-14,259,000$-15,476,000$-23,976,000$-20,287,000$-18,877,000$-17,190,000$-24,103,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-36,705,000$-32,333,000$-20,823,000$-19,530,000$-14,501,000$-14,259,000$-15,476,000$-23,976,000$-20,287,000$-18,877,000$-17,190,000$-24,103,000
    EBITDA$-35,889,000$-31,536,000$-20,907,000$-19,809,000$-14,393,000$-13,160,000$-13,815,000$-23,335,000$-19,222,000$-18,153,000$-16,729,000$-26,616,000
    EBIT$-36,137,000$-31,883,000$-20,931,000$-19,595,000$-14,329,000$-13,505,000$-14,222,000$-22,853,000$-19,392,000$-18,214,000$-16,950,000$-23,138,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SENS

    News

    SENS Q3'26 Earnings: revenue estimate is 16.20M USD

    Senseonics Holdings, Inc. (SENS) is scheduled to release its Q3'26 earnings on November 9, with an estimated revenue of $16.20 million and an anticipated EPS of ($0.52). The article provides a detailed table of past...

    TradingView•11/2/26•Neutral

    Senseonics stock trades at EUR 8.35 as Freedom study draws focus

    Senseonics Holdings (SENS) stock traded at EUR 8.35 on Lang & Schwarz on October 30, 2026, as the company initiated a first-in-human study for its new continuous glucose monitoring system...

    ad-hoc-news.de•10/30/26•Bullish

    Senseonics Holdings, Inc. (SENS) Seasonal Returns Chart

    The article provides a seasonal returns chart for Senseonics Holdings, Inc. (SENS), detailing average monthly price returns from 2016 to 2026. It also includes current stock information...

    Yahoo! Finance Canada•10/30/26•Neutral

    Senseonics Holdings, Inc. (SENS) Interactive Stock Chart

    This page provides an interactive stock chart for Senseonics Holdings, Inc. (SENS) on Yahoo Finance. It displays real-time price data, a summary, news...

    Yahoo! Finance Canada•10/29/26•Neutral

    BlackRock reports sole voting power over 2.7M Senseonics (SENS) shares in a passive stake update.

    BlackRock, Inc. has filed an amended passive investment disclosure (SCHEDULE 13G/A) for Senseonics Holdings, Inc. (SENS), reporting beneficial ownership of 2,743,263 shares...

    Stock Titan•10/27/26•Neutral

    SENS Valuation and Fair Value

    P/E
    -3.9x
    Forward P/E
    21.0x
    P/FCF
    -5.1x
    PEG
    0.0x
    P/B
    5.5x
    See GNG's fair value

    SENS Profitability: Margins, ROIC and FCF

    Gross margin
    54.9%
    Operating margin
    -248.5%
    Net margin
    -225.3%
    ROIC
    -58.7%
    ROE
    -118.2%
    FCF yield
    -19.5%

    SENS Competitors

    CompanyTicker
    XOMA CorpXOMA
    Strata Critical Medical, Inc.SRTA
    MiMedx Group IncMDXG
    Neuropace IncNPCE
    DiaMedica Therapeutics IncDMAC
    Alpha Teknova IncTKNO
    Avita Medical LtdRCEL
    Evolus IncEOLS

    Sector: Healthcare

    SENS Analyst Ratings

    Consensus
    Hold
    Analysts
    7
    Strong Buy
    0
    Buy
    4
    Hold
    2
    Sell
    0
    Strong Sell
    1

    SENS Bull Case vs Bear Case

    Bull case

    • SENS grew quarterly revenue 117.8% year over year.

    Bear case

    • SENS has a -225.3% net profit margin.
    • SENS beat EPS estimates in 25.0% of its last 8 reported quarters.

    SENS Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -298.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.52
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    SENS Earnings Date

    SENS reports Nov 9, 2026, after the close. The date is confirmed.

    SENS Earnings Call

    The latest SENS earnings call transcript on file is labeled 2026Q1.

    Read the 2026Q1 transcript

    SENS ETF Holders

    GNG tracks 6 ETFs that hold SENS. The largest weights:

    1. State Street SPDR S&P Health Care Equipment ETF (XHE), 0.56% of the fund
    2. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    3. iShares Core S&P Total U.S. Stock Market ETF (ITOT), <0.01% of the fund
    4. Schwab U.S. Broad Market ETF (SCHB), <0.01% of the fund
    5. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    Open the ETF Stock Exposure tool for SENS

    See insider activity

    Frequently Asked Questions About SENS

    When does SENS report earnings?

    Senseonics Holdings, Inc. Common Stock (SENS) is confirmed to report earnings on Nov 9, 2026.

    Does SENS pay dividends?

    Senseonics Holdings, Inc. Common Stock (SENS) does not currently pay a regular dividend.

    What is SENS's market cap?

    Senseonics Holdings, Inc. Common Stock (SENS) has a market capitalization of $476.92M with a current stock price of $8.59.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In